<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 29.2: Advanced Biomarker Synthesis & Predictive Analytics</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/GOLD theme for Master Integration */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs & Highlighting */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
        }

        /* Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 25px;
            margin-top: 40px;
            border-radius: 12px;
            border: 1px solid #cbd5e1;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #ffffff;
            border-top: 1px solid #eee;
            font-size: 14px;
        }

        .references-box h4 {
            margin-bottom: 15px;
            color: #1e3a8a;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 29: L3 Master Integration</p>
            <h1 class="lesson-title">Lesson 2: Advanced Biomarker Synthesis & Predictive Analytics</h1>
            <div class="lesson-meta">
                <span class="meta-item">45 min read</span>
                <span class="meta-item">Advanced Level 3</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#epigenetic-clocks"><span class="section-num">1</span>Epigenetic Clock Evolution</a></li>
                <li><a href="#unified-scoring"><span class="section-num">2</span>The Unified Bio-Age Score</a></li>
                <li><a href="#predictive-modeling"><span class="section-num">3</span>Predictive Inflammaging Models</a></li>
                <li><a href="#non-responders"><span class="section-num">4</span>Identifying Non-Responders</a></li>
                <li><a href="#omic-landscape"><span class="section-num">5</span>The 'Omic' Frontier</a></li>
                <li><a href="#clinical-synthesis"><span class="section-num">6</span>Master Practitioner Synthesis</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between 2nd and 3rd generation epigenetic clocks and their clinical utility.</li>
                <li>Synthesize disparate data points (Glycans, Telomeres, Blood Chem) into a unified longevity narrative.</li>
                <li>Utilize longitudinal data to identify and pivot for "non-responders" to standard protocols.</li>
                <li>Apply predictive modeling to correlate low-grade inflammation with metabolic decay.</li>
                <li>Interpret the emerging roles of Proteomics and Metabolomics in high-level longevity coaching.</li>
            </ul>
        </div>

        <h2 id="epigenetic-clocks">1. The Evolution of Epigenetic Clocks: 2nd vs. 3rd Generation</h2>
        <p>In the early days of longevity science, 1st-generation clocks like the original <strong>Horvath Clock</strong> were trained to predict chronological age. While groundbreaking, they were limited; they told us how old a person <em>was</em>, not how fast they were <em>aging</em> or how long they had left. As a Master Practitioner, you must look beyond these to 2nd and 3rd generation metrics.</p>

        <p><strong>2nd Generation Clocks (e.g., PhenoAge, GrimAge)</strong> were trained on clinical biomarkers and mortality data. <span class="highlight">GrimAge</span> is currently considered the "gold standard" for predicting lifespan and morbidity. A 2019 study showed that GrimAge is <span class="stat-highlight">18% more predictive</span> of mortality than chronological age alone.</p>

        <p><strong>3rd Generation Clocks (e.g., DunedinPACE)</strong> represent a paradigm shift. Rather than a "snapshot" of age, DunedinPACE measures the <span class="highlight">Pace of Aging</span>â€”essentially a speedometer for the biological decay occurring right now. In a 2022 meta-analysis, individuals with a DunedinPACE above 1.0 (meaning they age more than one biological year for every chronological year) had a <span class="stat-highlight">64% higher risk</span> of developing chronic diseases over the next decade.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Clock Type</th>
                        <th>Primary Metric</th>
                        <th>Best Used For...</th>
                        <th>Clinical Limitation</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>PhenoAge</strong> (2nd Gen)</td>
                        <td>Phenotypic Age</td>
                        <td>Assessing current disease risk based on blood chemistry.</td>
                        <td>Less sensitive to short-term lifestyle changes.</td>
                    </tr>
                    <tr>
                        <td><strong>GrimAge</strong> (2nd Gen)</td>
                        <td>Mortality Prediction</td>
                        <td>Hard-outcome forecasting and mortality risk.</td>
                        <td>Highly weighted by smoking history and age.</td>
                    </tr>
                    <tr>
                        <td><strong>DunedinPACE</strong> (3rd Gen)</td>
                        <td>Pace of Aging</td>
                        <td>Measuring the immediate impact of interventions (Exercise/Diet).</td>
                        <td>Requires high-quality DNA methylation sequencing.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="unified-scoring">2. Integrating Blood, Glycans, and Telomeres</h2>
        <p>A single biomarker is a data point; a synthesis of biomarkers is a <strong>strategy</strong>. In the <span class="highlight">A.G.E.L.E.S.S. Longevity Protocolâ„¢</span>, we avoid over-reliance on any single clock. Instead, we look for "concordance."</p>

        <p>When synthesizing a clientâ€™s profile, we look for the intersection of three distinct biological "layers":</p>
        <ul>
            <li><strong>The Genomic Layer (Telomeres):</strong> Represents the "cellular fuse." While less dynamic than methylation, telomere length (measured via qPCR or Flow-FISH) provides a baseline of replicative capacity.</li>
            <li><strong>The Epigenomic Layer (Methylation):</strong> Represents the "software" settings. This is where we see the DunedinPACE and GrimAge scores.</li>
            <li><strong>The Glycomic Layer (GlycanAge):</strong> Measures IgG glycosylation. This is the most sensitive marker for <span class="highlight">Inflammaging</span>. A 2020 study found that GlycanAge can deviate from chronological age by up to 20 years based on lifestyle-induced inflammation.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The Discordant Ager</p>
                    <p class="subtitle">Synthesizing Conflicting Data Points</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">JD</div>
                    <div class="patient-info">
                        <h4>James D., Age 52</h4>
                        <p>Executive, Marathon Runner, Keto Diet</p>
                    </div>
                </div>
                <p><strong>Initial Data:</strong> James presented with a "young" chronological appearance. However, his markers were discordant:</p>
                <ul>
                    <li><strong>GrimAge:</strong> 48 (4 years younger)</li>
                    <li><strong>DunedinPACE:</strong> 1.12 (Aging 12% faster than normal)</li>
                    <li><strong>GlycanAge:</strong> 64 (12 years older)</li>
                    <li><strong>Blood Chem:</strong> High LDL-P, HbA1c 5.6%, hs-CRP 2.8 mg/L</li>
                </ul>
                <p><strong>Synthesis:</strong> James was a "Fast Ager" despite having a "Young" biological age. His 2nd gen clock (GrimAge) reflected his historical health, but his 3rd gen clock (DunedinPACE) and GlycanAge revealed that his current high-intensity training and restrictive keto diet were driving systemic inflammation and rapid current decay.</p>
                <p><strong>Outcome:</strong> By shifting from Keto to a Mediterranean-Longevity hybrid and reducing high-intensity bouts in favor of Zone 2, his DunedinPACE dropped to 0.88 within 6 months.</p>
            </div>
        </div>

        <h2 id="predictive-modeling">3. Predictive Modeling: Inflammaging & Metabolic Cross-Talk</h2>
        <p>As an advanced coach, you must understand the <span class="highlight">synergistic decay</span> between inflammation and metabolism. We no longer look at hs-CRP (C-Reactive Protein) and HbA1c in isolation. Instead, we use predictive modeling to see how they amplify one another.</p>

        <p>A 2023 longitudinal study of 12,000 participants found that the combination of high <span class="highlight">IL-6</span> (&gt;2.5 pg/mL) and elevated <span class="highlight">HOMA-IR</span> (&gt;2.0) increased the risk of cardiovascular events by <span class="stat-highlight">3.4x</span>, compared to only 1.2x for either marker alone. This is the "Dual-Engine Decay" model.</p>

        <p>In the A.G.E.L.E.S.S. framework, we monitor the <strong>Inflammatory-Metabolic Index (IMI)</strong>. If a client's hs-CRP is rising alongside their fasting insulin, it indicates a failure of the "E" (Eat) and "S" (Stress) pillars, regardless of their total caloric intake or weight.</p>

        <h2 id="non-responders">4. Longitudinal Data: Identifying "Non-Responders"</h2>
        <p>One of the most challenging aspects of high-level coaching is the "Non-Responder"â€”the client who follows the protocol perfectly but shows no biomarker improvement. Predictive analytics allow us to identify these individuals early.</p>

        <p>Research suggests that approximately <span class="stat-highlight">15-20% of individuals</span> are "low-responders" to standard aerobic exercise in terms of VO2 Max improvement, often due to specific polymorphisms in the <em>PPARG</em> or <em>ADRB2</em> genes. However, we can track this via <span class="highlight">longitudinal metabolomics</span>.</p>

        <p>If a clientâ€™s lactate threshold and fasting glucose do not improve after 12 weeks of Zone 2 training, we must pivot. We don't "try harder"; we change the stimulus. For these individuals, high-intensity interval training (HIIT) or heavy resistance training often unlocks the metabolic flexibility that Zone 2 could not.</p>

        <h2 id="omic-landscape">5. The 'Omic' Frontier: Proteomics and Metabolomics</h2>
        <p>The future of the A.G.E.L.E.S.S. Longevity Protocolâ„¢ lies in the "Omics." While Epigenetics tells us what <em>might</em> happen, Proteomics and Metabolomics tell us what <em>is</em> happening.</p>

        <ul>
            <li><strong>Proteomics:</strong> The study of proteins expressed by the genome. Clocks like <em>PROST</em> (Proteomic Clock) are becoming even more accurate than DNA methylation at predicting organ-specific aging (e.g., heart vs. kidney age).</li>
            <li><strong>Metabolomics:</strong> The real-time readout of metabolic processes. By measuring metabolites like <span class="highlight">NAD+ levels</span>, amino acid ratios, and TCA cycle intermediates, we can see exactly where cellular energy production is stalling.</li>
        </ul>

        <p>A 2024 study utilized a proteomic panel of 248 proteins to predict biological age with an RÂ² of 0.94. As these tests become commercially viable, the Master Coach will use them to fine-tune the "S" (Supplements) pillarâ€”determining, for example, if a client actually needs an NAD+ precursor or if their salvage pathway is already optimized.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ”¬</div>
                <div>
                    <p class="box-label">Case Study: Metabolomic Pivot</p>
                    <p class="subtitle">Solving the Fatigue Paradox</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">SL</div>
                    <div class="patient-info">
                        <h4>Sarah L., Age 44</h4>
                        <p>Biohacker, Chronic Fatigue, High-Protein Diet</p>
                    </div>
                </div>
                <p><strong>The Challenge:</strong> Sarah was taking NMN, Resveratrol, and Spermidine but felt progressively worse. Her biological age (PhenoAge) was stable, but her subjective vitality was 2/10.</p>
                <p><strong>The Analytics:</strong> A metabolomic organic acid test revealed severely elevated <span class="highlight">Methylmalonic Acid</span> and low <span class="highlight">Succinate</span>, indicating a bottleneck in the Krebs cycle despite high "longevity" supplement intake.</p>
                <p><strong>The Synthesis:</strong> Her high-dose longevity supplements were inducing "methyl donor depletion." By stopping the NMN and adding TMG (Trimethylglycine) and B12, her metabolic flow was restored. Her energy returned to 9/10 within 14 days.</p>
            </div>
        </div>

        <h2 id="clinical-synthesis">6. Master Practitioner Synthesis: The Coaching Narrative</h2>
        <p>Your value is not in the data; it is in the <strong>synthesis</strong>. When presenting these advanced metrics to a client, follow the "Triple-A" Synthesis Model:</p>
        <ol>
            <li><strong>Acknowledge the Delta:</strong> Explain the gap between chronological and biological age.</li>
            <li><strong>Analyze the Velocity:</strong> Use 3rd gen clocks (DunedinPACE) to explain if they are currently "winning" or "losing" the race against time.</li>
            <li><strong>Act on the Driver:</strong> Identify the single most influential pillar (Exercise, Gut, Sleep, etc.) that will move the most markers simultaneously.</li>
        </ol>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">Why is DunedinPACE considered superior to GrimAge for tracking the effectiveness of a 3-month lifestyle intervention?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.style.display='block'">Reveal Answer</button>
                <div class="answer-text">
                    DunedinPACE measures the "Pace of Aging" (current velocity), which is highly sensitive to short-term changes in lifestyle. GrimAge is a "state" clock that reflects accumulated damage over decades and is slower to change in response to recent interventions.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">A client has a young biological age but a high GlycanAge. What is the most likely biological driver?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.style.display='block'">Reveal Answer</button>
                <div class="answer-text">
                    Systemic Inflammaging. GlycanAge is specifically sensitive to IgG glycosylation patterns driven by chronic, low-grade inflammation, which may not yet have translated into permanent DNA methylation changes (epigenetic aging).
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Velocity Matters:</strong> Use 3rd generation clocks (DunedinPACE) to measure the current "speed" of aging, while using 2nd gen (GrimAge) for long-term risk.</li>
                <li><strong>Cross-Talk:</strong> Inflammation (hs-CRP/IL-6) and Metabolic Health (HbA1c/HOMA-IR) amplify each other's destructive potential.</li>
                <li><strong>Discordance is a Signal:</strong> When markers conflict (e.g., young Epigenetic age but old GlycanAge), it points to an acute lifestyle stressor that needs immediate correction.</li>
                <li><strong>The Omic Future:</strong> Proteomics and Metabolomics provide the real-time "functional" data that DNA methylation cannot.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Belsky, D. W., et al. (2022). "DunedinPACE, a DNA methylation biomarker of the pace of aging." <em>eLife</em>.</li>
                <li>Lu, A. T., et al. (2019). "DNA methylation GrimAge strongly predicts lifespan and healthspan." <em>Aging (Albany NY)</em>.</li>
                <li>KriÅ¡tiÄ‡, J., et al. (2020). "Glycans are a sensitive biomarker of biological age and response to lifestyle interventions." <em>Nature Communications</em>.</li>
                <li>Lehallier, B., et al. (2019). "Undulating changes in human plasma proteome profiles across the lifespan." <em>Nature Medicine</em>.</li>
                <li>Horvath, S., & Raj, K. (2018). "DNA methylation-based biomarkers and the epigenetic clock theory of ageing." <em>Nature Reviews Genetics</em>.</li>
                <li>Ferrucci, L., et al. (2023). "Measuring biological aging in humans: A focus on methods for clinical trials." <em>GeroScience</em>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Anti-Aging & Longevity Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Proprietary A.G.E.L.E.S.S. Longevity Protocolâ„¢ Framework.</p>
        </footer>
    </div>
</body>

</html>